{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T06:52:54Z","timestamp":1763621574206},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,23]]},"DOI":"10.7759\/cureus.52814","type":"journal-article","created":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T00:29:11Z","timestamp":1706056151000},"source":"Crossref","is-referenced-by-count":1,"title":["Metabolic and Epigenetic Reprogramming in a Case of Nuclear Protein in Testis (NUT) Carcinoma of the Retroperitoneum"],"prefix":"10.7759","author":[{"given":"Mika","family":"Serizawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaho","family":"Serizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenta","family":"Masui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Toguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kumiko","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoji","family":"Nagashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshio","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Kurata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/pin.12727","article-title":"NUT carcinoma: clinicopathologic features, pathogenesis, and treatment","volume":"68","author":"French CA","year":"2018","unstructured":"French CA. NUT carcinoma: clinicopathologic features, pathogenesis, and treatment. Pathol Int. 2018, 68:583-95. 10.1111\/pin.12727","journal-title":"Pathol Int"},{"key":"ref2","article-title":"BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma","volume":"63","author":"French CA","year":"2003","unstructured":"French CA, Miyoshi I, Kubonishi I, Grier HE, Perez-Atayde AR, Fletcher JA. BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma. Cancer Res. 2003, 63:304-7.","journal-title":"Cancer Res"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2015.12.006","article-title":"The emerging hallmarks of cancer metabolism","volume":"23","author":"Pavlova NN","year":"2016","unstructured":"Pavlova NN, Thompson CB. The emerging hallmarks of cancer metabolism. Cell Metab. 2016, 23:27-47. 10.1016\/j.cmet.2015.12.006","journal-title":"Cell Metab"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1267\/ahc.20002","article-title":"Codependency of metabolism and epigenetics drives cancer progression: a review","volume":"53","author":"Masui K","year":"2020","unstructured":"Masui K, Harachi M, K Cavenee W, S Mischel P, Shibata N. Codependency of metabolism and epigenetics drives cancer progression: a review. Acta Histochem Cytochem. 2020, 53:1-10. 10.1267\/ahc.20002","journal-title":"Acta Histochem Cytochem"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/emboj.2010.176","article-title":"Oncogenesis by sequestration of CBP\/p300 in transcriptionally inactive hyperacetylated chromatin domains","volume":"29","author":"Reynoird N","year":"2010","unstructured":"Reynoird N, Schwartz BE, Delvecchio M, et al.. Oncogenesis by sequestration of CBP\/p300 in transcriptionally inactive hyperacetylated chromatin domains. EMBO J. 2010, 29:2943-52. 10.1038\/emboj.2010.176","journal-title":"EMBO J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e318198d666","article-title":"Diagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibody","volume":"33","author":"Haack H","year":"2009","unstructured":"Haack H, Johnson LA, Fry CJ, et al.. Diagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibody. Am J Surg Pathol. 2009, 33:984-91. 10.1097\/PAS.0b013e318198d666","journal-title":"Am J Surg Pathol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2013.03.004","article-title":"Influence of metabolism on epigenetics and disease","volume":"153","author":"Kaelin WG Jr","year":"2013","unstructured":"Kaelin WG Jr, McKnight SL. Influence of metabolism on epigenetics and disease. Cell. 2013, 153:56-69. 10.1016\/j.cell.2013.03.004","journal-title":"Cell"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-20-0024","article-title":"Dual regulation of histone methylation by mTOR complexes controls glioblastoma tumor cell growth via EZH2 and Sam","volume":"18","author":"Harachi M","year":"2020","unstructured":"Harachi M, Masui K, Honda H, et al.. Dual regulation of histone methylation by mTOR complexes controls glioblastoma tumor cell growth via EZH2 and Sam. Mol Cancer Res. 2020, 18:1142-52. 10.1158\/1541-7786.MCR-20-0024","journal-title":"Mol Cancer Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA119.011519","article-title":"mTORC2 links growth factor signaling with epigenetic regulation of iron metabolism in glioblastoma","volume":"294","author":"Masui K","year":"2019","unstructured":"Masui K, Harachi M, Ikegami S, et al.. mTORC2 links growth factor signaling with epigenetic regulation of iron metabolism in glioblastoma. J Biol Chem. 2019, 294:19740-51. 10.1074\/jbc.RA119.011519","journal-title":"J Biol Chem"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2013.09.013","article-title":"mTOR complex 2 controls glycolytic metabolism in glioblastoma through FoxO acetylation and upregulation of c-Myc","volume":"18","author":"Masui K","year":"2013","unstructured":"Masui K, Tanaka K, Akhavan D, et al.. mTOR complex 2 controls glycolytic metabolism in glioblastoma through FoxO acetylation and upregulation of c-Myc. Cell Metab. 2013, 18:726-39. 10.1016\/j.cmet.2013.09.013","journal-title":"Cell Metab"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-1153","article-title":"Clinicopathologic features and long-term outcomes of NUT midline carcinoma","volume":"18","author":"Bauer DE","year":"2012","unstructured":"Bauer DE, Mitchell CM, Strait KM, et al.. Clinicopathologic features and long-term outcomes of NUT midline carcinoma. Clin Cancer Res. 2012, 18:5773-9. 10.1158\/1078-0432.CCR-12-1153","journal-title":"Clin Cancer Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s12105-013-0496-2","article-title":"Utility of p40 in the differential diagnosis of small round blue cell tumors of the sinonasal tract","volume":"8","author":"Tilson MP","year":"2014","unstructured":"Tilson MP, Bishop JA. Utility of p40 in the differential diagnosis of small round blue cell tumors of the sinonasal tract. Head Neck Pathol. 2014, 8:141-5. 10.1007\/s12105-013-0496-2","journal-title":"Head Neck Pathol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.02.107","article-title":"Midline carcinoma of children and young adults with NUT rearrangement","volume":"22","author":"French CA","year":"2004","unstructured":"French CA, Kutok JL, Faquin WC, et al.. Midline carcinoma of children and young adults with NUT rearrangement. J Clin Oncol. 2004, 22:4135-9. 10.1200\/JCO.2004.02.107","journal-title":"J Clin Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2013.126","article-title":"MYC, a downstream target of BRD-NUT, is necessary and sufficient for the blockade of differentiation in NUT midline carcinoma","volume":"33","author":"Grayson AR","year":"2014","unstructured":"Grayson AR, Walsh EM, Cameron MJ, et al.. MYC, a downstream target of BRD-NUT, is necessary and sufficient for the blockade of differentiation in NUT midline carcinoma. Oncogene. 2014, 33:1736-42. 10.1038\/onc.2013.126","journal-title":"Oncogene"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.22862","article-title":"Molecular-genetic profiling and high-throughput in vitro drug screening in NUT midline carcinoma-an aggressive and fatal disease","volume":"8","author":"Stirnweiss A","year":"2017","unstructured":"Stirnweiss A, Oommen J, Kotecha RS, Kees UR, Beesley AH. Molecular-genetic profiling and high-throughput in vitro drug screening in NUT midline carcinoma-an aggressive and fatal disease. Oncotarget. 2017, 8:112313-29. 10.18632\/oncotarget.22862","journal-title":"Oncotarget"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/nature09504","article-title":"Selective inhibition of BET bromodomains","volume":"468","author":"Filippakopoulos P","year":"2010","unstructured":"Filippakopoulos P, Qi J, Picaud S, et al.. Selective inhibition of BET bromodomains. Nature. 2010, 468:1067-73. 10.1038\/nature09504","journal-title":"Nature"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/genes12020235","article-title":"Challenges and opportunities in NUT carcinoma research","volume":"12","author":"Hakun MC","year":"2021","unstructured":"Hakun MC, Gu B. Challenges and opportunities in NUT carcinoma research. Genes (Basel). 2021, 12:235. 10.3390\/genes12020235","journal-title":"Genes (Basel)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-3513","article-title":"Differentiation of NUT midline carcinoma by epigenomic reprogramming","volume":"71","author":"Schwartz BE","year":"2011","unstructured":"Schwartz BE, Hofer MD, Lemieux ME, et al.. Differentiation of NUT midline carcinoma by epigenomic reprogramming. Cancer Res. 2011, 71:2686-96. 10.1158\/0008-5472.CAN-10-3513","journal-title":"Cancer Res"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.25350","article-title":"Histone deacetylase inhibitor for NUT midline carcinoma","volume":"62","author":"Maher OM","year":"2015","unstructured":"Maher OM, Christensen AM, Yedururi S, Bell D, Tarek N. Histone deacetylase inhibitor for NUT midline carcinoma. Pediatr Blood Cancer. 2015, 62:715-7. 10.1002\/pbc.25350","journal-title":"Pediatr Blood Cancer"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2014.54","article-title":"Comparative drug screening in NUT midline carcinoma","volume":"110","author":"Beesley AH","year":"2014","unstructured":"Beesley AH, Stirnweiss A, Ferrari E, et al.. Comparative drug screening in NUT midline carcinoma. Br J Cancer. 2014, 110:1189-98. 10.1038\/bjc.2014.54","journal-title":"Br J Cancer"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-22-0591","article-title":"Report of the first international symposium on NUT carcinoma","volume":"28","author":"French CA","year":"2022","unstructured":"French CA, Cheng ML, Hanna GJ, et al.. Report of the first international symposium on NUT carcinoma. Clin Cancer Res. 2022, 28:2493-505. 10.1158\/1078-0432.CCR-22-0591","journal-title":"Clin Cancer Res"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/pin.13379","article-title":"Metabolic and epigenetic reprogramming in the pathogenesis of glioblastoma: toward the establishment of \"metabolism-based pathology\"","volume":"73","author":"Masui K","year":"2023","unstructured":"Masui K, Mischel PS. Metabolic and epigenetic reprogramming in the pathogenesis of glioblastoma: toward the establishment of \"metabolism-based pathology\". Pathol Int. 2023, 73:533-41. 10.1111\/pin.13379","journal-title":"Pathol Int"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/218901-metabolic-and-epigenetic-reprogramming-in-a-case-of-nuclear-protein-in-testis-nut-carcinoma-of-the-retroperitoneum","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:12:23Z","timestamp":1707509543000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/218901-metabolic-and-epigenetic-reprogramming-in-a-case-of-nuclear-protein-in-testis-nut-carcinoma-of-the-retroperitoneum"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,23]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.52814","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,23]]}}}